Achieving bacterial eradication using pharmacokinetic/pharmacodynamic principles (Q35168557)

6 August 2017

1 reference

title

Achieving bacterial eradication using pharmacokinetic/pharmacodynamic principles (English)

1 reference

eradication of infectious diseases

6 August 2017

main subject

1 reference

1 reference

1 reference

1

Ron Dagan

1 reference

6 August 2017

publication date

1 March 2003

1 reference

International Journal of Infectious Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

7 Suppl 1

1 reference

6 August 2017

page(s)

S21-6

1 reference

Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Prescribing antimicrobial agents for treatment of acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Efficacy of fixed combination antibiotics versus separate components in otitis media. Effectiveness of erythromycin estrolate, triple sulfonamide, ampicillin, erythromycin estolate- triple sulfonamide, and placebo in 280 patients with acute otitis m

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Penetration of ceftriaxone into the middle ear fluid of children

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990067-1

7 January 2021

10.1016/S1201-9712(03)90067-1

Identifiers

DOI

1 reference

6 August 2017

1 reference